>> 全站文章索引 >> 第3页:
  • Pharmacotherapy in the community-based treatment of children with bipolar I disorder - [Jeanette M. Jerrell]
  • White matter integrity of the whole brain is disrupted in first-episode remitted geriatric depression - [Yuan, Yongguia b; Zhang, Zhijuna c; Bai, Fenga]
  • Quality of web-based information on social phobia: a cross-sectional study - [Yasser Khazaal, M.D. 1, Sebastien Fernandez, M.A. 2, Sophie Cochand, B.A.]
  • Antidepressant response to partial sleep deprivation in unipolar depression is not related to state anxiety - [Camellia P. Clark, M.D., Shahrokh Golshan, Ph.D]
  • Review: Adding SSRIs to antipsychotics does not improve negative symptoms in people with schizophrenia - [AA Sepehry, S Potvin, R Elie]
  • Increased use of second generation antipsychotic drugs in primary care: potential relevance for hospitalizations in schizophrenia patients - [Macarena C. Cáceres1, Eva María Peñas-LLedó1, Alfredo de la Rubia2 and Adrián LLerena1, 3]
  • Understanding the comorbidity between early-onset dysthymia and cluster B personality disorders:a family study - [Riso LP, Klein DN, Ferro T, Kasch KL, Pepper CM, Schwartz JE, Aronson TA]
  • The comorbidity of borderline personality disorder and other DSM-III-R axis II personality disorders - [Nurnberg HG, Raskin M, Levine PE, Pollack S, Siegel O, Prince R]
  • Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders - [de Graaf R, Bijl RV, Smit F, Vollebergh WA, Spijker J]
  • Psychiatric comorbidity in patients with generalized anxiety disorder - [O Brawman-Mintzer, RB Lydiard, N Emmanuel, R Payeur, M Johnson, J Roberts, MP Jarrell and JC Balleng]
  • Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families - [McGough JJ, Smalley SL, McCracken JT, Yang M, Del]
  • Prevalence and comorbidity of mental disorders in persons making serious suicide attempts: a case-control study - [Beautrais AL, Joyce PR, Mulder RT, Fergusson DM, Deavoll BJ, Nightingale SK]
  • Obsessive-compulsive disorder: prevalence, comorbidity, impact, and help-seeking in the British National Psychiatric Morbidity Survey of 2000 - [Torres AR, Prince MJ, Bebbington PE, Bhugra D, Brugha TS, Farrell M, Jenkins R]
  • Mental disorders and comorbidity in suicide - [Markus M.Henriksson,M.D.,Hillevi M.Aro,M.D.,Ph.D]
  • Impact of psychiatric comorbidity on length of hospital stay for medical/surgical patients: a preliminary report - [Fulop G, Strain JJ, Vita J, Lyons JS, Hammer JS]
  • How the medical comorbidity of depressed patients differs across health care settings: results from the Medical Outcomes Study - [Wells KB, Rogers W, Burnam A, Greenfield S, Ware JE Jr]
  • Epidemiology and comorbidity of anxiety disorders in the elderly - [Flint AJ]
  • Diagnostic comorbidity in persons with suicidal ideation and behavior - [Rudd MD, Dahm PF, Rajab MH]
  • Depressive comorbidity in children and adolescents empirical theoretical and methodological issues - [Angold A, Costello EJ]
  • Anxiolytics for smoking cessation - [JR Hughes, LF Stead, T Lancaster]
  • Specificity and structure of obsessive-compulsive disorder symptoms - [Kevin D. Wu, Ph.D., Shawn A. Carter, B.A]
  • Costs of schizophrenia during 5 years - [E. Lindström1, J. Eberhard2, M. Neovius3, S. Levander4]
  • Thought Disorder in Euthymic Bipolar Patients: A Possible Endophenotype of Bipolar Affective Disorder? - [Osher, Yamima Phd; Bersudsky, Yuly Md]
  • Thought Disorder in Euthymic Bipolar Patients: A Possible Endophenotype of Bipolar Affective Disorder? - [Osher, Yamima Phd; Bersudsky, Yuly Md]
  • The Significance of Family History in First-Episode Schizophrenia Spectrum Disorder - [Norman, Ross M.G.Phd*; Manchanda, Rahul Md, Frcpc*; Malla]
  • Comorbidity of substance abuse and other psychiatric disorders in adolescents - [Oscar G.Bukstein,M.D.,M.P.H.,David A.Brent,M.D.,and Yifrah Kaminer,M.D]
  • Comorbidity of Borderline Personality Disorder With Other Personality Disorders in Hospitalized Adolescents and Adults - [Becker DF, Grilo CM, Edell WS, McGlashan TH]
  • Comorbidity of axis I and axis II disorders - [John M.Oldham,M.D.,Andrew E.Skodol,M.D]
  • Comorbidity of Axis I and Axis II Disorders in Patients Who Attempted Suicide - [Hawton K, Houston K, Haw C, Townsend E, Harriss L]
  • Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders - [Biederman J, Newcorn J, Sprich S]
  • Comorbidity in psychosis at first hospitalization - [Strakowski SM, Tohen M, Stoll AL, Faedda GL, Mayer PV, Kolbrener ML, Goodwin DC]
  • Comorbidity in mania at first hospitalization - [Strakowski SM, Tohen M, Stoll AL, Faedda GL, Goodwin DC]
  • Comorbidity in bipolar disorder among the elderly: results from an epidemiological community sample - [Goldstein BI, Herrmann N, Shulman KI]
  • Axis II Comorbidity of Substance Use Disorders Among Patients Referred for Treatment of Personality Disorders - [Skodol AE, Oldham JM, Gallaher PE]
  • Axis I Comorbidity of Borderline Personality Disorder - [Zanarini MC, Frankenburg FR, Dubo ED, Sickel AE, Trikha A, Levin A, Reynolds V]
  • Developing an intervention for depressed, chronically medically ill elders: a model from COPD - [George S. Alexopoulos, Patrick J. Raue, Jo Anne Sirey, Patricia A. Arean]
  • Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder - [K. Pennington, C L. Beasley, P. Dicker, A. Fagan, J. English, C M. Pariante]
  • Hypomanic symptoms predict an increase in narcissistic and histrionic personality disorder features in suicidal young adults - [Golan Shahar, Ph.D., Margaret-Ann Scotti, B.Sc. M. David Rudd]
  • A specific attentional bias in panic disorder - [Klara De Cort, M.Sc., Dirk Hermans, Ph.D. , Adriaan Spruyt, Ph.D. , Eric Griez]
  • Sex differences in symptom patterns of recurrent major depression in siblings - [Valentina Moskvina, Ph.D. , Anne Farmer, M.D., M.R.C.Psych.]
  • Adverse Effects of Atypical Antipsychotics: Differential Risk and Clinical Implications - [Peter M. Haddad1, Sonu G. Sharma]
  • Developmental expression profile of quaking, a candidate gene for schizophrenia - [Tara L. Lauriat, Lily Shiue , Vahram Haroutunian , Miguel Verbitsky]
  • The CATIE Schizophrenia Trial: Results, Impact, Controversy - [Theo C. Manschreck Roger A. Boshes]
  • Longitudinal Trajectories of Depression and Anxiety in a Prospective Community Study - [Kathleen Ries Merikangas, PhD; Heping Zhang, PhD; Shelli Avenevoli]
  • Somatic Symptoms and Physiologic Responses in Generalized Anxiety Disorder and Panic Disorder - [Hoehn-Saric R, McLeod DR, Funderburk F, Kowalski P]
  • Stable Prediction of Mood and Anxiety Disorders Based on Behavioral and Emotional Problems in Childhood - [Roza SJ, Hofstra MB, van der Ende J, Verhulst FC]
  • Complicated Grief as a Disorder Distinct From Bereavement-Related Depression and Anxiety: A Replication Study - [HG Prigerson, AJ Bierhals, SV Kasl, CF Reynolds 3rd, MK Shear]
  • The Empirical Basis of Generalized Anxiety Disorder - [Brown TA, Barlow DH, Liebowitz MR]
  • Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder - [Bruce SE, Yonkers KA, Otto MW, Eisen JL, Weisberg RB, Pagano M, Shea MT, Keller MB]
  • A Family Study of Generalized Anxiety Disorder - [R Noyes Jr, C Clarkson, RR Crowe, WR Yates and CM McChesney]
  • Antidepressant drugs in the treatment of anxiety disorders - [Allan Scott, Alan Davidson and Karen Palmer]
  • Functional Neuroimaging of Anxiety: A Meta-Analysis of Emotional Processing in PTSD, Social Anxiety Disorder, and Specific Phobia - [Etkin A, Wager TD]
  • Brief cognitive-behavioural therapies versus other brief psychological therapies for depression - [R Churchill, V Hunot, R Corney, M Knapp, H McGuire, A Tylee, S Wessely]
  • Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder - [KA Macritchie, JR Geddes, J Scott, DR Haslam, GM Goodwin]
  • The myelin-pathogenesis puzzle in schizophrenia: a literature review - [G. Karoutzou, H M. Emrich, D E. Dietrich, Professor Dr DE Dietrich]
  • Prevalence and symptomatology of depression in older people living in institutions in England and Wales - [F. A. McDougall,F. E. Matthews, K. Kvaal, M. E. Dewey3 and C. Brayne]
  • What do general medical guidelines say about depression care? Depression treatment recommendations in general medical practice guidelines - [Kilbourne, Amy Ma,b; Daugherty, Brandic; Pincus, Harold Aland]
  • New directions in the conceptualization of psychotic disorders - [Kroll, Jerome L]
  • Depression and anxiety in obstructive sleep apnea syndrome: a review - [T. Saunamäki, M. Jehkonen1]
  • Physical illness and schizophrenia: a review of the literature - [S. Leucht1, T. Burkard1, J. Henderson2, M. Maj3, N. Sartorius4]
  • Co-occurrence patterns of anxiety, depression and alcohol use disorders - [Naomar Almeida-Filho1, Ines Lessa2, Lucélia Magalhães2, Maria Jenny Araújo2, Estela Aquino2 and Jair]
  • The case for cothymia: mixed anxiety and depression as a single diagnosis PETER TYRER - [.]
  • The Comorbidity of Major Depression and Anxiety Disorders: Recognition and Management in Primary Care - [Hirschfeld RM]
  • Separation of anxiety and depressive disorders: blind alley in psychopharmacology and classification of disease - [Shorter E, Tyrer P]
  • Risk factors, prevalence, and treatment of anxiety and depressive disorders in Pakistan: systematic review - [Mirza I, Jenkins R]
  • Psychiatric and Somatic Markers of Anxiety: Identification and Pharmacologic Treatment - [Gelenberg AJ]
  • The DSM-IV field trial for mixed anxiety-depression - [Zinbarg RE, Barlow DH, Liebowitz M, Street L, Broadhead E, Katon W, Roy-Byrne P, Lepine JP, Teherani]
  • Duloxetine, 60 mg once daily, for major depressive: disorder a randomized double-blind placebo-controlled trial - [Detke MJ, Lu Y, Goldstein DJ, Hayes JR, Demitrack MA]
  • Pharmacokinetics and Safety of Duloxetine,a Dual-Serotonin and Norepinephrine Reuptake Inhibitor - [Sharma A, Goldberg MJ, Cerimele BJ]
  • Placebo interventions for all clinical conditions - [A Hróbjartsson, PC Gøtzsche]
  • Aripiprazole versus typicals for schizophrenia - [J Bhattacharjee, HGG El-Sayeh]
  • Gilbert's syndrome in a patient with predominantly negative symptoms of schizophrenia - [Andrew J. Powell ; Lars K. Hansen]
  • Common and Specific Dimensions of Self-Reported Anxiety and Depression in Adolescent Outpatients - [Robert A. Steer, David A. Clark, Geetha Kumar ,Aaron T. Beck]
  • Cat odour-induced anxiety—a study of the involvement of the endocannabinoid system - [Silva Sütt, Sirli Raud,Tarmo Areda, Ain Reimets, Sulev Kõks1,Eero Vasar]
  • Is depression a risk factor for heart complaints? : Longitudinal aspects in the Zurich study - [Dominique Eich, Christoph Neuhaus, Alex Gamma, Jules Angst]
  • The Maudsley early onset schizophrenia study : Predictors of psychosocial outcome at 4-year follow-up - [Nora S. Vyas, Michael Hadjulis, Apostolos Vourdas, Patrick Byrne , Sophia Frangou]
  • The DISC locus in psychiatric illness - [J E. Chubb, N J. Bradshaw, D C. Soares, D J. Porteous, J K. Millar, Dr KJ Millar]
  • Temporal lobe and “default” hemodynamic brain modes discriminate between schizophrenia and bipolar disorder - [Vince D. Calhoun , Paul K. Maciejewski , Godfrey D. Pearlson, Kent A. Kiehl]
  • Factors associated with antidepressant use in depressed and non-depressed community-dwelling elderly: the three-city study - [Agnès Soudry, Carole Dufouil ,Karen Ritchie ,Jean-François Dartigues]
  • The long term — Maximising potential for rehabilitation in patients with schizophrenia - [Andrea Fagiolini, Arianna Goracci]
  • Three-year antipsychotic effectiveness in the outpatient care of schizophrenia: Observational versus randomized studies results - [Josep Maria Haro, David Suarez, Diego Novick, Jacqueline Brown]
  • Maintenance electroconvulsive therapy (ECT) for treatment-resistant disorganized schizophrenia - [Eiji Shimizu, Masao Imai, Mihisa Fujisaki, Naoyuki Shinoda, Satoshi Handa]
  • Low dosage tricyclic antidepressants for depression - [T Furukawa, H McGuire, C Barbui]
  • Amisulpride versus other atypical antipsychotics for schizophrenia - [K Komossa, C Rummel, H Hunger, F Schmidt, S Schwarz, JIS Mota Neto, S Leucht]
  • Schizophrenia with prominent catatonic features (‘catatonic schizophrenia ’).II. Factor analysis of the catatonic syndrome - [Gabor S. Ungvari,William Goggins, Siu-Kau Leung ,Jozsef Gerevich]
  • Improvement in antipsychotic-related metabolic disturbances in patients with schizophrenia switched to ziprasidone - [José Manuel Montes ,Jose Luis Rodriguez, Eduardo Balbo, Pedro Sopelana]
  • Prolactin and estradiol serum levels in unmedicated male paranoid schizophrenia patients - [Michael Segala,Avi Avitalc,Severina Berstein]
  • Assessment of malondialdehyde levels in schizophrenia: A meta-analysis and some methodological considerations - [Sylvain Grignon,Jean Marc Chianetta]
  • Heterogeneity of Treatment Effects in Schizophrenia - [T. Scott Stroup MD, MPH]
  • Basal ganglia volumes in drug-naive first-episode schizophrenia patients before - [Andreas Glenthoj,Birte Y.Glenthoj,Torben Mackeprang,Anne K.Pagsberg]
  • What do symptoms mean - [.]
  • What Are the Right Targets for Psychopharmacology - [Hyman SE, Fenton WS]
  • "Unexplained" somatic symptoms, functional syndromes, and somatization: do we need a paradigm shift - [Sharpe M, Carson A]
  • Trends of probable post-traumatic stress disorder in New York City after the September 11 terrorist attacks - [Galea S, Vlahov D, Resnick H, Ahern J, Susser E, Gold J, Bucuvalas M, Kilpatrick D]
  • Treatment process and outcomes for managed care patients receiving new antidepressant prescriptions from psychiatrists and primary care physicians - [Simon GE, Von Korff M, Rutter CM, Peterson DA]
  • The Relationship Between Antidepressant Prescription Rates and Rate of Early Adolescent Suicide - [Gibbons RD, Hur K, Bhaumik DK, Mann JJ]
  • The Relationship Between Antidepressant Medication Use and Rate of Suicide - [Gibbons RD, Hur K, Bhaumik DK, Mann JJ]
  • The Maudsley long-term follow-up of child and adolescent depression. 2. Suicidality, criminality and social dysfunction in adulthood - [Fombonne E, Wostear G, Cooper V, Harrington R, Rutter M]
  • Suicide Risk in Bipolar Disorder During Treatment With Lithium and Divalproex - [Goodwin FK, Fireman B, Simon GE, Hunkeler EM, Lee J, Revicki D]
  • Suicide Risk During Antidepressant Treatment - [Gregory E. Simon, M.D., M.P.H., James Savarino, Ph.D]


    • 分页: 1 2 [3] 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40
    41 42 43 44 45 46 47 48 49 50